Sources
zerohedgeFDA Removing Pharmaceutical Representatives From Advisory Panels https://t.co/G1poZowRzg
INFOWARSFDA To Remove Pharma Reps from Advisory Panels https://t.co/ntY5eETXMG
Persimmon Tree Investments$XBI — $BBIO $RARE $RCKT $TSHA More Megyn Kelly Makary — it sounds like this gentleman wants to outMarks Marks. Accelerated approval on one RCT in some cases, and new accelerated pathway for rare diseases based on “plausible mechanism” with conditional approval with follow up
Additional media




